RPS6 was regarded as the core target due to its highest BC value, and the other 5 genes, including MAPK1, MAPK3, MDM2, DDX5, and TP53, were identified as the key target genes thanks to their higher BC value too. This evidence concerns the gene MAPK3 and breast cancer.